glp-1 obesity drug news today oct 2025 Lilly launches pill, kicking off showdown with Novo Nordisk GLP-1 Agonists Market Report 2025-2033,

Hyperuricemia as a mediator of the proinammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome

Allulose may be gut-friendly, by analogy to other low-digestible sweeteners that also reach the colon intact and are fermented by bacteria to produce SCFAs

This can lead to obstructive jaundice, a serious condition in which bilirubin a pigment found in bile builds up in your body

Aggressive mixing can damage the molecular structure and reduce potency

Heres a checklist of what to look for: Experienced Staff : Ensure the specialists are knowledgeable and can answer your questions confidently